Haanstad Meredith, Seeley Leslie D, Srinivas Tara, Chamot Matthew, Haanstad Trevor, Marotta Christopher, Sethu Palaniappan, Jayaraman Ambalavanan
TDA Research, Inc., Wheat Ridge, Colorado, USA.
Division of Cardiovascular Disease, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Artif Organs. 2025 Apr;49(4):670-680. doi: 10.1111/aor.14919. Epub 2024 Dec 13.
Hyperkalemia, the buildup of serum potassium to levels >6 mEq L, has been a recognized complication of combat injuries such as acute kidney injury since World War II. Currently, renal replacement therapy (RRT) serves as the standard of care for hyperkalemic patients who fail to respond to medical management. However, RRT is difficult to administer in combat settings, and the time between evacuation and RRT is critical in preventing post-traumatic hyperkalemia. Therefore, the need for portable, easily operable hemofiltration technology is pressing to improve the survival of hyperkalemic patients in austere settings.
In this manuscript, we present extra-corporeal direct contact and hemodialysis filtration systems for treating severe hyperkalemia and tested the efficacy, biocompatibility, and performance of a zeolite-based renal RRT. We tested the uptake capacity of an adsorbent zeolite optimized for the selective binding and removal of potassium in various mediums, including dialysate, bovine serum, and whole bovine sodium heparinized blood.
Our results show that we can restore physiological normokalemic levels within just 2 h of testing and maintain these levels for 6 h. Furthermore, calcium and sodium levels were maintained within normal physiological ranges, confirming the selectivity of our sorbent material for potassium binding.
高钾血症,即血清钾水平升高至>6 mEq/L,自第二次世界大战以来一直是诸如急性肾损伤等战斗创伤公认的并发症。目前,肾脏替代疗法(RRT)是对药物治疗无反应的高钾血症患者的标准治疗方法。然而,在战斗环境中难以实施RRT,且后送与RRT之间的时间对于预防创伤后高钾血症至关重要。因此,迫切需要便携式、易于操作的血液滤过技术,以提高高钾血症患者在艰苦环境中的生存率。
在本论文中,我们展示了用于治疗严重高钾血症的体外直接接触和血液透析滤过系统,并测试了基于沸石的肾脏RRT的疗效、生物相容性和性能。我们测试了一种经过优化的吸附性沸石在各种介质(包括透析液、牛血清和全牛肝素化血液)中对钾的选择性结合和去除的摄取能力。
我们的结果表明,在测试仅2小时内就能恢复生理正常血钾水平,并将这些水平维持6小时。此外,钙和钠水平维持在正常生理范围内,证实了我们的吸附剂材料对钾结合的选择性。